Cargando…

Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation

No distinct guidelines are available regarding the effect of pretransplant locoregional treatment (LRT) in hepatocellular carcinoma (HCC) staging system. The aim of this study was to investigate the prognosis of pathologic downstaging (PDS) by the exclusion of total necrosis after liver transplantat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Deok Gie, Lee, Jae Geun, Joo, Dong Jin, Kim, Soon Il, Kim, Myoung Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637173/ https://www.ncbi.nlm.nih.gov/pubmed/31316165 http://dx.doi.org/10.1038/s41598-019-46871-9

Ejemplares similares

Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
por: Crocetti, Laura, et al.
Publicado: (2021)

Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Choi, Mun Chae, et al.
Publicado: (2022)

Downstaging of Hepatocellular Carcinoma Prior to Liver Transplant: Is There a Role for Adjuvant Sorafenib in Locoregional Therapy?
por: Vagefi, Parsia A., et al.
Publicado: (2010)

Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation
por: Biolato, Marco, et al.
Publicado: (2021)

Hepatocellular Carcinoma: Downstaging to Liver Transplantation as Curative Therapy
por: Frankul, Leana, et al.
Publicado: (2021)

Cumulative exposure to tacrolimus during early period after liver transplantation does not affect the recurrence of hepatocellular carcinoma
por: Kim, Deok-Gie, et al.
Publicado: (2023)

Liver transplantation in hepatocellular carcinoma – should we perform downstaging?
por: Filipec Kanižaj, Tajana, et al.
Publicado: (2022)

Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
por: Kang, Incheon, et al.
Publicado: (2021)

Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation—Adjusting the Odds?
por: Seehofer, Daniel, et al.
Publicado: (2022)

Liver Resection after Downstaging Hepatocellular Carcinoma with Sorafenib
por: Barbier, L., et al.
Publicado: (2011)

Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplant
por: Yin, Chao, et al.
Publicado: (2022)

Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors
por: Gao, Qimeng, et al.
Publicado: (2021)

The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea
por: Kim, Kunhee, et al.
Publicado: (2023)

Clinical association between tacrolimus intra-patient variability and liver transplantation outcomes in patients with and without hepatocellular carcinoma
por: Kim, Hyun Jeong, et al.
Publicado: (2022)

Risk Factors for Cytomegalovirus Infection and Its Impact on Survival after Living Donor Liver Transplantation in South Korea: A Nested Case-Control Study
por: Yim, Seung Hyuk, et al.
Publicado: (2023)

European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma
por: Claasen, Marco Petrus Adrianus Wilhelmus, et al.
Publicado: (2023)

Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
por: Yoo, Eun Jin, et al.
Publicado: (2013)

Rituximab protects against development of atherosclerotic cardiovascular disease after kidney transplantation: a propensity-matched study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report
por: Joo, Dong Jin, et al.
Publicado: (2021)

Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study
por: Yim, Seung Hyuk, et al.
Publicado: (2023)

Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2019)

Predicted Impact of the Model for End-Stage Liver Disease 3.0 in a Region Suffering Severe Organ Shortage
por: Kim, Deok-Gie, et al.
Publicado: (2023)

Unusual grafts for living-donor liver transplantation
por: Yim, Seung Hyuk, et al.
Publicado: (2023)

Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma
por: Shehta, Ahmed, et al.
Publicado: (2020)

Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes
por: Di Martino, Marcello, et al.
Publicado: (2022)

Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation
por: Hwang, Hyeo Seong, et al.
Publicado: (2022)

Association between post-transplant uric acid level and renal allograft fibrosis: Analysis using Banff pathologic scores from renal biopsies
por: Kim, Deok Gie, et al.
Publicado: (2018)

Corrigendum: Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma
por: Shehta, Ahmed, et al.
Publicado: (2021)

Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study
por: Lee, Juhan, et al.
Publicado: (2019)

Hepatocellular carcinoma in old age: are there any benefits of liver resection in old age?
por: Shin, In Sik, et al.
Publicado: (2020)

Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy
por: Han, Dai Hoon, et al.
Publicado: (2016)

Graft-versus-host disease after simultaneous pancreas-kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2020)

Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or “Wait and See” Strategy?
por: Vitale, Alessandro, et al.
Publicado: (2021)

Expression Patterns of Tumor Markers in Liver Transplant Recipients Showing Complete Pathological Response of Hepatocellular Carcinoma
por: Kim, Min-Jae, et al.
Publicado: (2022)

Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging
por: Affonso, Breno Boueri, et al.
Publicado: (2019)

Predicting the outcomes of hepatocellular carcinoma downstaging with the use of clinical and radiomics features
por: Wang, Si-Yuan, et al.
Publicado: (2023)

The recovery status from delayed graft function can predict long-term outcome after deceased donor kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2017)

Adefovir- or Lamivudine-Induced Renal Tubular Dysfunction after Liver Transplantation
por: Lee, Jae Geun, et al.
Publicado: (2015)

Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
por: Rhu, Jinsoo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4a786bsaohgmcv7autc7hptnll